Literature DB >> 10496273

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

M W Nortvedt1, T Riise, K M Myhr, H I Nyland.   

Abstract

OBJECTIVE: To compare the Expanded Disability Status Scale (EDSS) and self-rated quality of life scores (SF-36 Health Survey) as measures of disease impact in a representative sample of MS patients.
BACKGROUND: The EDSS is the most common outcome measure of impairment/disability for MS patients but is heavily weighted toward mobility. Sensitive outcome measures are needed that also capture other aspects of the effects of MS.
METHODS: The authors performed a cross-sectional study of the cohort of all individuals with onset of MS between 1976 and 1986 who were diagnosed before 1995 in Hordaland County, Norway. A total of 194 patients (94%) participated.
RESULTS: The patients had lower mean scores for all eight SF-36 health dimensions compared with sex- and age-adjusted scores in a general population. EDSS scores correlated highly with physical functioning (r = -0.86, R2 = 0.73), and explained some of the variation in social functioning (r = -0.48, R2 = 0.23) and general health (r = -0.46, R2 = 0.21) but little for the other dimensions.
CONCLUSIONS: The SF-36 captures the broad effects of MS, and the results showed that patients also are bothered frequently with health problems such as bodily pain and low vitality. These problems, which are not reflected in the Expanded Disability Status Scale, should be given more attention in the treatment of MS and when evaluating interventions.

Entities:  

Mesh:

Year:  1999        PMID: 10496273     DOI: 10.1212/wnl.53.5.1098

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  67 in total

1.  Bidirectional associations between alcohol consumption and health-related quality of life amongst young and middle-aged women.

Authors:  I C Schrieks; M Y Wei; E B Rimm; O I Okereke; I Kawachi; H F J Hendriks; K J Mukamal
Journal:  J Intern Med       Date:  2015-12-20       Impact factor: 8.989

2.  Quality of life and impairment in patients with multiple sclerosis.

Authors:  A-K Isaksson; G Ahlström; L-G Gunnarsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

3.  Cognition and physical disability in predicting health-related quality of life in multiple sclerosis.

Authors:  Marietta Hoogs; Sukhmit Kaur; Audrey Smerbeck; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Int J MS Care       Date:  2011

Review 4.  A critical appraisal of treatment decisions in multiple sclerosis--old versus new.

Authors:  Bernd C Kieseier; Olaf Stüve
Journal:  Nat Rev Neurol       Date:  2011-04-05       Impact factor: 42.937

Review 5.  [Coping with multiple sclerosis in partnerships: a systematic review of the literature].

Authors:  A-K Busch; R Spirig; W Schnepp
Journal:  Nervenarzt       Date:  2014-06       Impact factor: 1.214

6.  Cumulative impact of comorbidity on quality of life in MS.

Authors:  R A Marrie; R Horwitz; G Cutter; T Tyry
Journal:  Acta Neurol Scand       Date:  2011-05-26       Impact factor: 3.209

7.  Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients.

Authors:  Maura Pugliatti; Trond Riise; Monica W Nortvedt; Giovanni Carpentras; M Alessandra Sotgiu; Stefano Sotgiu; Giulio Rosati
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

Review 8.  Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.

Authors:  Richard A Rudick; Deborah M Miller
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  The study circle as a tool in multiple sclerosis patient education in Sweden.

Authors:  Anne-Marie Landtblom; Cecilia Lang; Gullvi Flensner
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

10.  The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis.

Authors:  Haleh Ghaem; Afshin Borhani Haghighi
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.